Nom du produit:methyl 2-(4-bromophenyl)acetate
IUPAC Name:methyl 2-(4-bromophenyl)acetate
- CAS：41841-16-1
- Formule moléculaire：C9H9BrO2
- Pureté：95%+
- Numéro de catalogue：CM107979
- Poids moléculaire：229.07
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:41841-16-1
- Formule moléculaire:C9H9BrO2
- Point de fusion:-
- Code SMILES:O=C(OC)CC1=CC=C(Br)C=C1
- Densité:
- Numéro de catalogue:CM107979
- Poids moléculaire:229.07
- Point d'ébullition:
- N° Mdl:MFCD00126844
- Stockage:Keep in a dry and a tight container and store at ambient temperature
Category Infos
- Benzenes
- Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.
Column Infos
- Carbonyl Compounds
- In organic chemistry, a carbonyl group is a functional group with the formula C=O, composed of a carbon atom double-bonded to an oxygen atom, and it is divalent at the C atom. It is common to several classes of organic compounds (such as aldehydes, ketones and carboxylic acids), as part of many larger functional groups. A compound containing a carbonyl group is often referred to as a carbonyl compound.
- Aprocitentan
- New Phase 3 data with aprocitentan for patients with resistant hypertension has been presented at the American Society of Nephrology Kidney Week 2023.
Aprocitentan is an investigational, novel, oral, dual endothelin receptor antagonist (ERA), which potently inhibits the binding of ET-1 to ETA and ETB receptors. Aprocitentan has a low potential for drug-drug interaction and a mechanism of action that is ideally suited for the pathophysiology of resistant hypertension.
A new drug application (NDA) for aprocitentan was accepted for review by the US FDA.
Recherche 
+86 21 5895 0110 
